Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
47.46
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
May 06, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 20.2% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts'...
Via
StockStory
Topics
Artificial Intelligence
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
May 06, 2025
Good news for Hims & Hers stock spooks Lilly and Novo investors.
Via
The Motley Fool
Topics
Earnings
Which stocks are most active on Tuesday?
May 06, 2025
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via
Chartmill
Earnings Scheduled For May 5, 2025
May 05, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 06, 2025
Via
Benzinga
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition
May 06, 2025
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q1 CY2025, with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded...
Via
StockStory
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential
May 06, 2025
Hims & Hers stock is now giving investors another reason to consider it a buy for the coming months, as the latest quarterly earnings show momentum.
Via
MarketBeat
What's Going On With Hims & Hers Stock Tuesday?
May 06, 2025
Hims & Hers stock was trading lower but has since reversed and began trading higher after the company reported first-quarter earnings on Monday after the market closed.
Via
Benzinga
Looking At Hims & Hers Health's Recent Unusual Options Activity
May 06, 2025
Via
Benzinga
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
May 06, 2025
Via
Benzinga
Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook
May 06, 2025
The company recently inked a deal with Novo Nordisk. But will that bolster current-quarter sales?
Via
Investor's Business Daily
Hims & Hers Stock Slides Pre-Market As Q2 Sales View Misses Estimates, But Retail Traders Shrug It Off
May 06, 2025
Its second-quarter revenue guidance of $530 million-$550 million fell short of the $564.57 million consensus estimate.
Via
Stocktwits
Topics
Earnings
Hims & Hers Health’s (NYSE:HIMS) Q1: Beats On Revenue, Full-Year Outlook Slightly Exceeds Expectations
May 05, 2025
Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 111% year on year to $586 million. Revenue guidance for the full...
Via
StockStory
Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares Slide
May 05, 2025
Hims & Hers Health reports first-quarter revenue of $586.01 million, beating estimates of $538.2 million, according to Benzinga.
Via
Benzinga
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
May 05, 2025
From
Hims & Hers
Via
Business Wire
ETFs Last Week: Tech-Fueled Rally Powers Gains During Trade Optimism
May 05, 2025
Wall Street rebounds from tariff losses, with S&P 500 recording second consecutive weekly gain. Top performers were tech giants and leveraged ETFs.
Via
Benzinga
Topics
ETFs
Stocks
World Trade
10 Health Care Stocks Whale Activity In Today's Session
May 05, 2025
Via
Benzinga
Hims & Hers Names New COO. Stock Rallies.
May 05, 2025
Hims stock rose Monday after the telehealth program named technology industry veteran Nader Kabbani as its new chief operating officer.
Via
Investor's Business Daily
Topics
Government
Stocks
World Trade
Hims & Hers Appoints Ex-Amazon Exec Ahead Of Q1 Results
May 05, 2025
Hims & Hers Health shares are trading marginally lower Monday morning. The company earlier appointed Nader Kabbani as its new Chief Operations Officer, ahead of Q1 results.
Via
Benzinga
Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery
May 05, 2025
Hims & Hers Health Inc. (NYSE:HIMS) partners with Novo Nordisk to offer affordable weight-loss drug, positioning itself to expand into other healthcare areas.
Via
Benzinga
Hims & Hers Appoints Amazon Veteran Nader Kabbani COO To Support Expansion
May 05, 2025
A nearly 20-year Amazon veteran, Nader Kabbani said he was drawn to Hims & Hers by its potential to expand access to fast, reliable, and high-quality care.
Via
Stocktwits
Topics
Artificial Intelligence
Economy
Government
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
May 05, 2025
From
Hims & Hers
Via
Business Wire
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
May 04, 2025
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them?
Via
Benzinga
Topics
Artificial Intelligence
Hims & Hers Health Earnings: What To Look For From HIMS
May 04, 2025
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results tomorrow after the bell. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Why Is Novo Nordisk Stock Trading Higher On Friday?
May 02, 2025
Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease affecting patients with obesity.
Via
Benzinga
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
May 02, 2025
GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock investors.
Via
The Motley Fool
Topics
World Trade
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
May 01, 2025
Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access initiatives.
Via
Benzinga
Where Is Hims & Hers Stock Headed After Wegovy Tie-Up? Retail Traders Bet On Rebound To Over 2-Month High
May 01, 2025
Needham called the tie-up a “groundbreaking partnership” and said it alleviates investor concerns around Hims’ ability to hit its 2025 weight loss revenue guidance.
Via
Stocktwits
Hims & Hers Stock Soars on Novo Nordisk Collaboration
April 30, 2025
Hims & Hers stock rallies by over 25% on news of a collaboration with Novo Nordisk and its weight loss flagship products, and that's not all.
Via
MarketBeat
Most active stocks in Tuesday's session
April 29, 2025
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.